Payment overview · 2025
General Payments
$17.18
1 reported records · 1 companies
Healthcare provider profile · identity verified
Anthony John Stugan, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · SOMERSET, KY · NPI 1700800844
Verified facts
What the public records show
CMS Open Payments records show Anthony John Stugan, M.D. received $17.18 in general payments during 2025 across 1 reported records.
Phathom Pharmaceuticals, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $17.18 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $17.18 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $17.18 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 523 | 165 |
| Omeprazole | Omeprazole | 504 | 138 |
| Levothyroxine Sodium | Levothyroxine Sodium | 495 | 121 |
| Gabapentin | Gabapentin | 488 | 107 |
| Losartan Potassium | Losartan Potassium | 432 | 126 |
| Amlodipine Besylate | Amlodipine Besylate | 426 | 143 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 413 | 130 |
| Metformin Hcl | Metformin Hcl | 306 | 103 |
| Lisinopril | Lisinopril | 248 | 82 |
| Pantoprazole Sodium | Pantoprazole Sodium | 241 | 87 |
| Metoprolol Succinate | Metoprolol Succinate | 230 | 75 |
| Potassium Chloride | Potassium Chloride | 217 | 72 |
| Furosemide | Furosemide | 209 | 70 |
| Alprazolam | Alprazolam | 201 | 48 |
| Metoprolol Tartrate | Metoprolol Tartrate | 197 | 74 |
| Tamsulosin Hcl | Tamsulosin Hcl | 191 | 55 |
| Montelukast Sodium | Montelukast Sodium | 187 | 59 |
| Eliquis | Apixaban | 181 | 51 |
| Simvastatin | Simvastatin | 161 | 43 |
| Duloxetine Hcl | Duloxetine Hcl | 160 | 42 |
| Allopurinol | Allopurinol | 157 | 43 |
| Hydrochlorothiazide | Hydrochlorothiazide | 149 | 53 |
| Clopidogrel | Clopidogrel Bisulfate | 145 | 44 |
| Trulicity | Dulaglutide | 144 | 27 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 139 | 55 |
| Tramadol Hcl | Tramadol Hcl | 135 | 30 |
| Pravastatin Sodium | Pravastatin Sodium | 134 | 43 |
| Celecoxib | Celecoxib | 132 | 40 |
| Carvedilol | Carvedilol | 130 | 38 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 123 | 38 |
| Jardiance | Empagliflozin | 121 | 31 |
| Ropinirole Hcl | Ropinirole Hcl | 120 | 27 |
| Escitalopram Oxalate | Escitalopram Oxalate | 118 | 34 |
| Trazodone Hcl | Trazodone Hcl | 117 | 33 |
| Clonazepam | Clonazepam | 112 | 29 |
| Prednisone | Prednisone | 108 | 49 |
| Glimepiride | Glimepiride | 107 | 31 |
| Ezetimibe | Ezetimibe | 106 | 29 |
| Metformin Hcl Er | Metformin Hcl | 105 | 39 |
| Meloxicam | Meloxicam | 99 | 26 |
| Mounjaro | Tirzepatide | 98 | 19 |
| Sertraline Hcl | Sertraline Hcl | 95 | 32 |
| Famotidine | Famotidine | 94 | 28 |
| Fluticasone Propionate | Fluticasone Propionate | 90 | 40 |
| Ozempic | Semaglutide | 88 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 86 | 26 |
| Lorazepam | Lorazepam | 83 | 23 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 82 | 26 |
| Fluconazole | Fluconazole | 81 | 26 |
| Azithromycin | Azithromycin | 76 | 66 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 75 | 55 |
| Farxiga | Dapagliflozin Propanediol | 75 | 20 |
| Nifedipine Er | Nifedipine | 70 | 19 |
| Pioglitazone Hcl | Pioglitazone Hcl | 70 | 21 |
| Buspirone Hcl | Buspirone Hcl | 68 | 24 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 68 | 20 |
| Levofloxacin | Levofloxacin | 68 | 35 |
| Atenolol | Atenolol | 66 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 66 | 12 |
| Promethazine Hcl | Promethazine Hcl | 66 | 17 |
| Valsartan | Valsartan | 61 | 15 |
| Entresto | Sacubitril/Valsartan | 60 | 13 |
| Spironolactone | Spironolactone | 60 | 15 |
| Warfarin Sodium | Warfarin Sodium | 60 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 58 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 58 | 24 |
| Methocarbamol | Methocarbamol | 56 | 15 |
| Cephalexin | Cephalexin | 55 | 46 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 53 | 14 |
| Memantine Hcl | Memantine Hcl | 50 | 14 |
| Mirtazapine | Mirtazapine | 50 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 48 | 16 |
| Lansoprazole | Lansoprazole | 48 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 48 | 14 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 47 | 13 |
| Alendronate Sodium | Alendronate Sodium | 46 | 18 |
| Chlorthalidone | Chlorthalidone | 46 | 12 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 41 | 33 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 41 | suppressed |
| Xarelto | Rivaroxaban | 41 | 12 |
| Temazepam | Temazepam | 40 | 11 |
| Topiramate | Topiramate | 39 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 39 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 38 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 38 | 31 |
| Pregabalin | Pregabalin | 38 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 38 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 37 | 11 |
| Baclofen | Baclofen | 37 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 36 | 14 |
| Glipizide | Glipizide | 36 | 14 |
| Lovastatin | Lovastatin | 36 | 11 |
| Synthroid | Levothyroxine Sodium | 36 | 12 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 36 | 16 |
| Meclizine Hcl | Meclizine Hcl | 35 | suppressed |
| Ondansetron Odt | Ondansetron | 35 | 18 |
| Ranolazine Er | Ranolazine | 35 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 34 | 17 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 33 | 13 |
| Amoxicillin | Amoxicillin | 32 | 31 |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 32 | suppressed |
| Ibuprofen | Ibuprofen | 31 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 30 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 30 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 29 | suppressed |
| Finasteride | Finasteride | 29 | suppressed |
| Nitroglycerin | Nitroglycerin | 28 | 16 |
| Benazepril Hcl | Benazepril Hcl | 27 | suppressed |
| Januvia | Sitagliptin Phosphate | 27 | suppressed |
| Lamotrigine | Lamotrigine | 27 | suppressed |
| Torsemide | Torsemide | 27 | 15 |
| Doxazosin Mesylate | Doxazosin Mesylate | 25 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 25 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 25 | suppressed |
| Irbesartan | Irbesartan | 24 | suppressed |
| Levetiracetam | Levetiracetam | 24 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 23 | suppressed |
| Nystatin | Nystatin | 23 | 15 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 22 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 22 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 21 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 21 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 21 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 20 | suppressed |
| Clonidine | Clonidine | 20 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 20 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 20 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 19 | 11 |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 19 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 19 | suppressed |
| Diazepam | Diazepam | 18 | suppressed |
| Felodipine Er | Felodipine | 18 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 17 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 17 | suppressed |
| Phenobarbital | Phenobarbital | 17 | suppressed |
| Acyclovir | Acyclovir | 16 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 16 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 16 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 16 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 16 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 16 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 16 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 15 | 14 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 15 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 14 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 14 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 14 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 14 | suppressed |
| Anastrozole | Anastrozole | 13 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 13 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 13 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 13 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 13 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 13 | suppressed |
| Methylprednisolone | Methylprednisolone | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 12 | suppressed |
| Rexulti | Brexpiprazole | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 12 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 12 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 12 | suppressed |
| Bupropion Xl | Bupropion Hcl | 11 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Dutasteride | Dutasteride | 11 | suppressed |
| Elmiron | Pentosan Polysulfate Sodium | 11 | suppressed |
| Praluent Pen | Alirocumab | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
| Tradjenta | Linagliptin | 11 | suppressed |
| Xifaxan | Rifaximin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $17.18 · 1 records | Phathom Pharmaceuticals, Inc. | VOQUEZNA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error